Scientists make significant discovery in the fight against drug-resistant tuberculosisAllbiopro2018-09-22T10:45:54+09:009월 22nd, 2018|
New Analytical Instrument Could Change Vaccine Development Through Faster Viral DetectionAllbiopro2018-09-22T10:44:58+09:009월 22nd, 2018|
EMA Recommends New Gene Therapy for Rare Inherited Disorder for ApprovalAllbiopro2018-09-22T10:44:03+09:009월 22nd, 2018|
Pfizer, Merck and Johnson & Johnson shifting profits to avoid billions in tax payments each year: reportAllbiopro2018-09-21T01:52:40+09:009월 21st, 2018|
Allergan, eyeing Asia for growth, pours $14.7M into first medical aesthetics center in ChinaAllbiopro2018-09-21T01:52:13+09:009월 21st, 2018|
Racing with Merck, Pfizer wins FDA ‘breakthrough’ tag for 20-valent pneumococcal vaccineAllbiopro2018-09-21T01:51:46+09:009월 21st, 2018|
Mylan, Fujifilm score EU thumbs-up for Humira biosimilar, putting more pressure on AbbVieAllbiopro2018-09-21T01:51:19+09:009월 21st, 2018|
Novartis’ Alcon adds online training portal to supplement in-person eyecare education centersAllbiopro2018-09-21T01:50:53+09:009월 21st, 2018|
Amicus joins gene therapy surge with $100M pipeline purchaseAllbiopro2018-09-21T01:50:27+09:009월 21st, 2018|
Kymera taps former Alnylam executive Jared Gollob as CMOAllbiopro2018-09-21T01:50:01+09:009월 21st, 2018|
Newly identified human skeletal stem cell could lead to bone regenerative therapiesAllbiopro2018-09-21T01:49:36+09:009월 21st, 2018|
Tvardi Therapeutics raises $9M series A for STAT3 inhibitorsAllbiopro2018-09-21T01:49:10+09:009월 21st, 2018|
Trial takes FibroGen’s renal anemia drug closer to EU filingAllbiopro2018-09-21T01:48:44+09:009월 21st, 2018|
Corbus nets over 600 endocannabinoid-related compounds, planning to develop 1-2 per yearAllbiopro2018-09-21T01:48:19+09:009월 21st, 2018|
Exicure plans checkpoint combo after TLR9 drug clears early testAllbiopro2018-09-21T01:47:52+09:009월 21st, 2018|
3 international charities to fund £30M post-Brexit cancer research modelAllbiopro2018-09-21T01:47:27+09:009월 21st, 2018|
Lonza targets both early and late-stage biotech in $415m Ibex expansionAllbiopro2018-09-21T01:46:59+09:009월 21st, 2018|
